Статья

Understanding the alphaviruses: Recent research on important emerging pathogens and progress towards their control

E. Gould, B. Coutard, H. Malet, B. Morin, S. Jamal, S. Weaver, A. Gorbalenya, G. Moureau, C. Baronti, I. Delogu, N. Forrester, M. Khasnatinov, T. Gritsun, L. de, B. Canard,
2021

The alphaviruses were amongst the first arboviruses to be isolated, characterized and assigned a taxonomic status. They are globally very widespread, infecting a large variety of terrestrial animals, insects and even fish, and circulate both in the sylvatic and urban/peri-urban environment, causing considerable human morbidity and mortality. Nevertheless, despite their obvious importance as pathogens, there are currently no effective antiviral drugs with which to treat humans or animals infected by any of these viruses. The EU-supported project-VIZIER (Comparative Structural Genomics of Viral Enzymes Involved in Replication, FP6 Project: 2004-511960) was instigated with an ultimate view of contributing to the development of antiviral therapies for RNA viruses, including the alphaviruses [Coutard, B., Gorbalenya, A.E., Snijder, E.J., Leontovich, A.M., Poupon, A., De Lamballerie, X., Charrel, R., Gould, E.A., Gunther, S., Norder, H., Klempa, B., Bourhy, H., Rohayemj, J., L'hermite, E., Nordlund, P., Stuart, D.I., Owens, R.J., Grimes, J.M., Tuckerm, P.A., Bolognesi, M., Mattevi, A., Coll, M., Jones, T.A., Åqvist, J., Unger, T., Hilgenfeld, R., Bricogne, G., Neyts, J., La Colla, P., Puerstinger, G., Gonzalez, J.P., Leroy, E., Cambillau, C., Romette, J.L., Canard, B., 2008. The VIZIER project: preparedness against pathogenic RNA viruses. Antiviral Res. 78, 37-46]. This review highlights some of the major features of alphaviruses that have been investigated during recent years. After describing their classification, epidemiology and evolutionary history and the expanding geographic distribution of Chikungunya virus, we review progress in understanding the structure and function of alphavirus replicative enzymes achieved under the VIZIER programme and the development of new disease control strategies. © 2009 Elsevier B.V.

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • E. Gould
    Institut de Recherche pour le Développement UMR190/Unité des Virus Emergents, Université de la Méditerranée, Marseille, France
  • B. Coutard
    Architecture et Fonction des Macromolécules Biologiques, CNRS and Universités d'Aix-Marseille I et II, UMR 6098, ESIL, Case 925, 13288 Marseille, France
  • H. Malet
    Department of Pathology, University of Texas Medical Branch, Galveston, TX, United States
  • B. Morin
    Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands
  • S. Jamal
    Centre for Ecology and Hydrology, Mansfield Road, Oxford OX1 3SR, United Kingdom
  • S. Weaver
    School of Biological Sciences (AMS Building), University of Reading, Berks RG6 6AJ, United Kingdom
  • A. Gorbalenya
    Laboratory of Transmissive Infections, Institute of Epidemiology and Microbiology, Karl Marks 3, 664025 Irkutsk, Russian Federation
  • G. Moureau
  • C. Baronti
  • I. Delogu
  • N. Forrester
  • M. Khasnatinov
  • T. Gritsun
  • L. de
  • B. Canard
Название журнала
  • Antiviral Research
Том
  • 87
Выпуск
  • 2
Страницы
  • 111-124
Ключевые слова
  • alpha interferon; carbodine; chloroquine; genomic RNA; glycoprotein; live vaccine; nonstructural protein 1; nonstructural protein 2; nonstructural protein 3; nonstructural protein 4; peginterferon alpha; quinine; ribavirin; virus vaccine; enzyme; virus protein; Alpha virus; antiviral activity; antiviral therapy; Barmah Forest virus; biogeography; Chikungunya alphavirus; crystal structure; disease control; drug efficacy; Eastern equine encephalomyelitis virus; evolution; geographic distribution; human; immune response; molecular phylogeny; nonhuman; pathogenesis; priority journal; protein function; research; review; RNA virus; Semliki Forest alphavirus; Sindbis virus; virion; virus entry; virus replication; Western equine encephalomyelitis alphavirus; Alpha virus; Alphavirus Infections; animal; chemistry; classification; Communicable Diseases, Emerging; drug effects; enzymology; European Union; genetics; medical research; metabolism; organization and management; pathogenicity; trends; virology; Alphavirus; Alphavirus Infections; Animals; Biomedical Research; Chikungunya virus; Communicable Diseases, Emerging; Enzymes; European Union; Humans; Viral Proteins; Alphavirus; Animalia; Arbovirus; Chikungunya virus; Hexapoda; RNA viruses; Alphavirus; Alphavirus Infections; Animals; Biomedical Research; Chikungunya virus; Communicable Diseases, Emerging; Enzymes; European Union; Humans; Viral Proteins
Тип документа
  • Review
Источник
  • scopus